# Autologous Bone Marrow Transplantation in Acute Non-Lymphoblastic Leukemia During First or Subsequent Remission

> **NCT00186381** · PHASE2 · COMPLETED · sponsor: **Stanford University** · enrollment: 200 (estimated)

## Conditions studied

- Leukemia, Myelocytic, Acute
- Leukemia
- Blood and Marrow Transplant (BMT)

## Interventions

- **PROCEDURE:** high dose chemotherapy then autologous hematopoietic cell transplant

## Key facts

- **NCT ID:** NCT00186381
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1995-11
- **Primary completion:** 2007-03
- **Final completion:** 2007-03
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2010-07-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00186381

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00186381, "Autologous Bone Marrow Transplantation in Acute Non-Lymphoblastic Leukemia During First or Subsequent Remission". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00186381. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*